Oppenheimer (NYSE:OPY) Downgraded by Wall Street Zen to Hold

Oppenheimer (NYSE:OPY - Get Free Report) was downgraded by Wall Street Zen from a "strong-buy" rating to a "hold" rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings upgraded Oppenheimer from a "buy (b-)" rating to a "buy (b)" rating in a research report on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Oppenheimer presently has an average rating of "Buy".

Oppenheimer Price Performance

NYSE:OPY opened at $95.16 on Friday. The business has a fifty day simple moving average of $95.68 and a two-hundred day simple moving average of $82.15. Oppenheimer has a 1 year low of $60.89 and a 1 year high of $118.77. The company has a market capitalization of $1.02 billion, a P/E ratio of 11.34 and a beta of 1.19.

Oppenheimer (NYSE:OPY - Get Free Report) last released its earnings results on Friday, May 1st. The financial services provider reported $4.21 earnings per share (EPS) for the quarter. The business had revenue of $445.10 million during the quarter. Oppenheimer had a return on equity of 17.49% and a net margin of 5.66%.

Insider Buying and Selling

In other Oppenheimer news, insider Dennis P. Mcnamara sold 4,673 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $90.67, for a total transaction of $423,700.91. Following the completion of the transaction, the insider owned 20,177 shares of the company's stock, valued at $1,829,448.59. This represents a 18.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 34.86% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP grew its holdings in shares of Oppenheimer by 1.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 497,033 shares of the financial services provider's stock worth $44,329,000 after acquiring an additional 7,384 shares during the period. Vanguard Group Inc. grew its holdings in shares of Oppenheimer by 2.5% during the 3rd quarter. Vanguard Group Inc. now owns 426,033 shares of the financial services provider's stock worth $31,488,000 after acquiring an additional 10,345 shares during the period. American Century Companies Inc. grew its holdings in shares of Oppenheimer by 17.3% during the 3rd quarter. American Century Companies Inc. now owns 299,211 shares of the financial services provider's stock worth $22,115,000 after acquiring an additional 44,145 shares during the period. Millennium Management LLC grew its holdings in shares of Oppenheimer by 56.6% during the 4th quarter. Millennium Management LLC now owns 114,737 shares of the financial services provider's stock worth $8,294,000 after acquiring an additional 41,485 shares during the period. Finally, Royce & Associates LP grew its holdings in shares of Oppenheimer by 18.0% during the 3rd quarter. Royce & Associates LP now owns 112,404 shares of the financial services provider's stock worth $8,308,000 after acquiring an additional 17,122 shares during the period. Institutional investors own 32.26% of the company's stock.

About Oppenheimer

Oppenheimer & Co Inc is a full-service investment bank and wealth management firm headquartered in New York City. Founded in the mid-20th century, the company provides a broad array of financial services to individual, institutional and corporate clients. Its core competencies include equity and fixed-income research, institutional sales and trading, underwriting and merger-and-acquisition advisory.

In the wealth management segment, Oppenheimer offers tailored investment solutions, comprehensive financial planning and retirement strategies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.